Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma × liposomal doxorubicin × Clear all

Phase

Phase 2 7 Phase 1 3 Phase 1/2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Breast Neoplasms 2 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 24 Rituximab 16 fludarabine phosphate 13 Radiotherapy 12 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Filgrastim 10 Cytarabine 10 Methotrexate 9 Exercise 9 Doxorubicin 9 Cyclosporine 9 Busulfan 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Prednisone 6 Prednisolone 6 Methods 6 Etoposide 6 Educational Status 6 Early Intervention, Educational 6 Blood Specimen Collection 6 Palliative Care 5 Leucovorin 5 fludarabine 4 Geriatric Assessment 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00141648 2009-10-01

Chemotherapy and Radiotherapy for Osteolymphoma

Trans Tasman Radiation Oncology Group

Phase NA Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡